Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Preventing de novo portal vein thrombosis with Antithrombin-III in patients with cirrhosis: A randomized, double-blinded, placebo - controlled trial (PiVoT-AC Trial)

Portal vein thrombosis (PVT) is blockage or narrowing of the portal vein (the blood vessel that brings blood to the liver from the intestines) by a blood clot. It is a common complication in patients with cirrhosis. There is an understanding that patients with cirrhosis are at higher risk for clotting events. This study will examine the use of antithrombin III (a protein found in the body) as a potential drug that may prevent blood clotting in patients with cirrhosis.
18 year(s) or older
This study is NOT accepting healthy volunteers
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adults age ≥18 or ≤75 years
Cirrhosis diagnosis
Exclusion Criteria:
active Hepatitis C infection
HIV infection
recent major surgery within six weeks
Digestive Systems & Liver Disease
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Hershey, PA